相关实验视频
Updated: May 3, 2026
06:55
Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
20.0K
概括
这项研究旨在利用生物信息学在糖尿病足中识别与自相关的基因. 然而,由于受损的同行评审过程,该文章已被撤回.
科学领域:
- 生物医学科学 生物医学科学
- 遗传学 是一个遗传学.
- 糖尿病并发症 糖尿病并发症
背景情况:
- 糖尿病足 (DFU) 是糖尿病的一种严重并发症,其特点是伤口愈合受损.
- 自,细胞降解过程,在伤口愈合中起着至关重要的作用,并与糖尿病有关.
- 识别特定的自相关基因 (ARG) 可能为DFU治疗提供新的治疗点.
研究的目的:
- 通过全面的生物信息分析,识别与糖尿病足相关的关键自相关基因 (ARG).
- 探索这些已识别的ARG在DFU病原和进展中的潜在作用.
- 为开发有针对性的疗法提供基础,以改善DFU愈合.
主要方法:
- 利用与糖尿病足相关的公开可用的基因表达数据集.
- 采用生物信息工具和数据库来选和识别不同表达的与自相关的基因.
- 进行路径丰富分析和蛋白质-蛋白质相互作用网络构建,以了解基因功能和相互作用.
主要成果:
- 确定了一组与自相关的候选基因,这些基因在糖尿病足中显著失调.
- 突出了特定的ARG,可能与DFU中的炎症反应和细胞外矩阵重塑有关.
- 生物信息分析表明,糖尿病患者的伤口愈合受损的潜在分子机制.
结论:
- 该研究确定了几个与自相关的基因作为糖尿病足的潜在生物标志物和治疗标.
- 这些发现有助于理解DFU病变的分子基础.
- 需要进一步的实验验证,以确认已识别的ARG在DFU愈合中的作用.
更多相关视频
08:16High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
3.4K
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
2.7K
相关概念视频
02:46Genetic Screens
4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
01:05Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
01:27Glucose Transporters
15.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
01:11Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17